therapeutic proteins are now established biologics, with high activity against many ocular diseases. However, design of novel drug delivery systems to achieve a non-toxic, constant and efficient delivery with minimal doses of therapeutic proteins is still challenging. Several factors, such as the protein aggregation, unfolding for improving bioavailability of protein to the retina, interactions of biologics with the retina, diffusion in the vitreous, penetration inside the retinal layers, and finally elimination from the eye needs to be carefully studied
OMICS Group International is one of the leading Open Access Publishers which is publishing 700+ peer-reviewed journals with the support of 50,000+ editorial board members as editorial team and aimed to disseminate the scholarly knowledge to the scientific society.
Last date updated on January, 2021